生物
细胞生物学
DNA损伤
活力测定
程序性细胞死亡
激酶
衰老
癌变
细胞周期
检查点激酶2
细胞
癌症研究
细胞凋亡
蛋白激酶A
DNA
癌症
生物化学
遗传学
丝氨酸苏氨酸激酶
作者
Reut Yosef,Noam Pilpel,Nurit Papismadov,Hilah Gal,Yossi Ovadya,Ezra Vadai,Stav Miller,Ziv Porat,Shifra Ben‐Dor,Valery Krizhanovsky
出处
期刊:The EMBO Journal
[Springer Nature]
日期:2017-06-12
卷期号:36 (15): 2280-2295
被引量:211
标识
DOI:10.15252/embj.201695553
摘要
Abstract Cellular senescence is a permanent state of cell cycle arrest that protects the organism from tumorigenesis and regulates tissue integrity upon damage and during tissue remodeling. However, accumulation of senescent cells in tissues during aging contributes to age‐related pathologies. A deeper understanding of the mechanisms regulating the viability of senescent cells is therefore required. Here, we show that the CDK inhibitor p21 ( CDKN 1A) maintains the viability of DNA damage‐induced senescent cells. Upon p21 knockdown, senescent cells acquired multiple DNA lesions that activated ataxia telangiectasia mutated ( ATM ) and nuclear factor ( NF )‐κB kinase, leading to decreased cell survival. NF ‐κB activation induced TNF ‐α secretion and JNK activation to mediate death of senescent cells in a caspase‐ and JNK ‐dependent manner. Notably, p21 knockout in mice eliminated liver senescent stellate cells and alleviated liver fibrosis and collagen production. These findings define a novel pathway that regulates senescent cell viability and fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI